Company profile for Hyloris Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Hyloris is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. We unlock the untapped potentials of existing medications to create new and improved treatment options. We develop innovative proprietary products that offer significant advantages compared to currently available alternatives. Our aim is to address the unmet medical needs of pa...
Hyloris is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. We unlock the untapped potentials of existing medications to create new and improved treatment options. We develop innovative proprietary products that offer significant advantages compared to currently available alternatives. Our aim is to address the unmet medical needs of patients, hospitals, physicians, payors and other stakeholders in the healthcare system.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Boulevard Gustave Kleyer 17, 4000 Liège,
Telephone
Telephone
+32 (0)4 346 02 07
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/redhill-biopharma-announces-full-year-2024-financial-results-and-operational-highlights-302425587.html

PR NEWSWIRE
10 Apr 2025

https://www.globenewswire.com//news-release/2024/03/14/2845976/0/en/Hyloris-Reports-Full-Year-Results-for-2023-Provides-Business-Outlook.html

GLOBENEWSWIRE
14 Mar 2024

https://www.globenewswire.com//news-release/2024/03/14/2845961/0/en/Communication-at-the-request-of-the-FSMA-on-the-transactions-with-Qliniq.html

GLOBENEWSWIRE
14 Mar 2024

https://www.globenewswire.com/news-release/2024/03/08/2842882/0/en/Hyloris-to-Report-2023-Full-Year-Results-on-14-March-2024.html

GLOBENEWSWIRE
08 Mar 2024

https://www.globenewswire.com//news-release/2024/02/14/2829330/0/en/Hyloris-Enrolls-First-Patient-in-Phase-3-Clinical-Trial-for-its-Proprietary-Mouth-Rinse-to-Control-Incidences-of-Bleeding-Related-to-Dental-Procedures.html

GLOBENEWSWIRE
14 Feb 2024

https://www.globenewswire.com/news-release/2024/01/30/2819574/0/en/Hyloris-and-Purna-Female-Healthcare-Announce-Positive-Results-from-Phase-2-Trial-in-Patients-with-Acute-Vulvovaginal-Candidiasis-VVC.html

GLOBENEWSWIRE
30 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty